ArticleRedox biology2019

aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1.

Li Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.